No Benefit Found for Perioperative Statin Therapy

Share this content:
No Benefit Found for Perioperative Statin Therapy
No Benefit Found for Perioperative Statin Therapy

THURSDAY, May 5, 2016 (HealthDay News) -- Taking statins right before cardiac surgery, once touted as a way to prevent common postoperative complications, has no benefit and may even cause harm, according to a study published in the May 5 issue of the New England Journal of Medicine.

Barbara Casadei, M.D., a professor of cardiovascular medicine at the University of Oxford in the United Kingdom, and colleagues randomly assigned 1,922 patients who were having elective cardiac surgery to take rosuvastatin or placebo before surgery.

The researchers found that patients given rosuvastatin had lower levels of low-density lipoprotein cholesterol and C-reactive protein after surgery, compared with patients given a placebo. However, the percentages of those who developed atrial fibrillation were essentially the same in patients given rosuvastatin (21.1 percent) and those given a placebo (20.5 percent). Further analyses showed that rosuvastatin was associated with a 5.4 percent greater chance of acute kidney injury, when compared with a placebo.

"The risk of kidney injury is relatively small, but considering that the benefit of statin treatment before a heart operation is zero, one may well consider stopping statins for a few days before surgery," Casadei told HealthDay.

The study was funded in part by AstraZeneca, the manufacturer of rosuvastatin.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Incidence of death or cardiac arrest 1.74 per 100,000 participants; higher incidence in men, with age

ACP Does Not Support Legalization of Assisted Suicide

ACP Does Not Support Legalization of Assisted Suicide

Legalization would affect trust in the patient-physician relationship, and in the medical profession

AAP: Epinephrine Admin Training Needed in Many Schools

AAP: Epinephrine Admin Training Needed in Many Schools

In 2015 to 2016, 2.7 percent reported that epinephrine was administered by unlicensed staff

is free, fast, and customized just for you!

Already a member?

Sign In Now »